Laverock Therapeutics

Laverock Therapeutics is a biotechnology company developing a programmable gene control platform for the creation of disease-responsive advanced therapies.

The platform uses recoded microRNAs to deliver tunable, stable and multiplexed gene silencing within cell therapies, enabling enhanced precision and improved safety profiles.

Laverock's internal pipeline targets oncology and genetic medicine, with lead programmes in T-cell and macrophage immunotherapy.